Yazar "Cabuk, Devrim" için listeleme
-
HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy
Kahraman, Seda; Hizal, Mutlu; Gumusay, Ozge; Basaran, Gul; Seyyar, Mustafa; Sahin, Elif; Cabuk, Devrim (2025)Aim: Hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative breast cancer which represents the most common subgroup of metastatic breast cancer (MBC). Recently, further subclassification for ... -
The Role of Immune-Inflammation Biomarkers to Predict the Response of Nivolumab in Second Line Treatment of Advanced Stage Non-Small Cell Lung Cancer
Ozkul, Ozlem; Sahin, Elif; Cabuk, Devrim; Sever, Nadiye; Majıdova, Nargız; Bayoglu, İbrahim Vedat; Culha, Yaşar (2024)Objectives: In this study, the relationship between response to second-line nivolumab treatment in advanced non- small cell lung cancer (NSCLC) and systemic immune inflammation index (SII) was investigated. Methods: One ...
